China vs Europe & Central Asia (IDA & IBRD countries): Cause of death, by non-communicable diseases, ages 15-59, female

China
82.6%
in 2021
Europe & Central Asia (IDA & IBRD countries)
60.3%
in 2021
China rank
18th
Europe & Central Asia (IDA & IBRD countries) rank
17th

Cause of death, by non-communicable diseases, ages 15-59, female over time

  • China
  • Europe & Central Asia (IDA & IBRD countries)
020406080200020102021

How they compare

China currently reports 82.6% against 60.3% in Europe & Central Asia (IDA & IBRD countries), a difference of 22.3%.

That makes China's figure about 1.4 times Europe & Central Asia (IDA & IBRD countries)'s.

The two have swapped places 1 time across 6 shared years of data; in 2000 it was Europe & Central Asia (IDA & IBRD countries) ahead.

China ranks 18th and Europe & Central Asia (IDA & IBRD countries) ranks 17th of 185 countries.

Across the 3 decades both report, China averaged higher in 1 and Europe & Central Asia (IDA & IBRD countries) in 2.

Head to head by decade

Decade China Europe & Central Asia (IDA & IBRD countries) Difference Ahead
2000s 74.1% 76.2% 2.2% Europe & Central Asia (IDA & IBRD countries)
2010s 79.3% 80.2% 0.9% Europe & Central Asia (IDA & IBRD countries)
2020s 82.0% 63.7% 18.3% China

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 15-59, female, China or Europe & Central Asia (IDA & IBRD countries)?
China, at 82.6% against 60.3% in Europe & Central Asia (IDA & IBRD countries) as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between China and Europe & Central Asia (IDA & IBRD countries)?
22.3%, with China ahead.
How many years of comparable data are there for China and Europe & Central Asia (IDA & IBRD countries)?
6 years are reported by both, from 2000 to 2021.
How do China and Europe & Central Asia (IDA & IBRD countries) rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
China ranks 18th and Europe & Central Asia (IDA & IBRD countries) ranks 17th of 185 countries.
Where does this data come from?
Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

China vs Europe & Central Asia (IDA & IBRD countries): Cause of death, by non-communicable diseases, ages 15-59, female. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-15-59-female-percent-of-total-female/china/europe-and-central-asia-ida-and-ibrd-countries/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-15-59-female-percent-of-total-female/china/europe-and-central-asia-ida-and-ibrd-countries/">China vs Europe & Central Asia (IDA & IBRD countries): Cause of death, by non-communicable diseases, ages 15-59, female</a> — Statizoid

About this data

Indicator
Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59)
Unit
% of total female deaths ages 15-59
Source
Global Health Estimates, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 1,392 data points, 2000–2021
Last refreshed

Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.